{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:52:37Z","timestamp":1790200357789,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R00 EY029373"],"award-info":[{"award-number":["R00 EY029373"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY035658"],"award-info":[{"award-number":["R01 EY035658"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ischemia-induced retinopathy is a defining feature of prevalent ocular conditions, including diabetic retinopathy and central retinal artery or vein occlusion. Therapeutic interventions for ischemic retinopathies show limited efficacy and adverse effects, highlighting the need to thoroughly investigate the underlying mechanisms. Histone deacetylase 3 (HDAC3), a member of the histone deacetylase family, plays a central role in regulating gene expression in myeloid cells (microglia and macrophages). We recently showed that myeloid HDAC3 deletion promotes tissue repair and functional recovery after retinal ischemia-reperfusion (IR) injury via efferocytosis, a process by which myeloid cells engulf and clear apoptotic cells. Here, we investigated the mechanism by which myeloid HDAC3 deletion enhances efferocytosis. Employing an in vitro efferocytosis assay coupled with RNA sequencing on HDAC3 KO macrophages revealed that the secreted protein, CD5 molecule-like (CD5L), was the most upregulated among other pro-efferocytic genes. In vivo, we found that CD5L levels markedly increased in the retinas of myeloid HDAC3 KO mice subjected to IR injury, and its expression colocalized with myeloid cells. Co-immunoprecipitation experiments showed that HDAC3 represses CD5L expression in a liver X receptor (LXR\u03b1)-dependent manner. Additionally, we found that CD36, a receptor for CD5L that facilitates the clearance of apoptotic cells, was upregulated in retinal myeloid cells after IR. In vitro, CD5L treatment enhanced efferocytosis via CD36. We then evaluated the role of CD5L in retinal IR injury using in vivo neuronal, vascular, structural, and functional endpoints. CD5L KO mice showed worsened outcomes after IR, whereas treatment with recombinant CD5L was protective against retinal ischemic injury. Collectively, our findings suggest that deleting HDAC3 enhances macrophage efferocytosis by upregulating the CD5L\/CD36 axis. CD5L may serve as a promising therapeutic target to improve outcomes in ischemic retinopathy.<\/jats:p>","DOI":"10.1038\/s41419-026-08752-8","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:28:00Z","timestamp":1776670080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CD5L promotes efferocytosis and resolution of retinal ischemic injury"],"prefix":"10.1038","volume":"17","author":[{"given":"Rami A.","family":"Shahror","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyanan","family":"Chuesiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa","family":"Shosha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuet-Kin","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-7881","authenticated-orcid":false,"given":"Shengyu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3042-9425","authenticated-orcid":false,"given":"Abdelrahman Y.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"8752_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101354","volume":"46","author":"AP Marques","year":"2022","unstructured":"Marques AP, Ramke J, Cairns J, Butt T, Zhang JH, Jones I, et al. The economics of vision impairment and its leading causes: a systematic review. EClinicalMedicine. 2022;46:101354.","journal-title":"EClinicalMedicine"},{"key":"8752_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1172\/jci.insight.93751","volume":"2","author":"EJ Duh","year":"2017","unstructured":"Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017;2:14.","journal-title":"JCI Insight"},{"key":"8752_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03159-8","volume":"21","author":"RA Shahror","year":"2024","unstructured":"Shahror RA, Shosha E, Morris C, Wild M, Mu S, Csanyi G, et al. Deletion of myeloid hdac3 promotes efferocytosis to ameliorate retinal ischemic injury. J Neuroinflamm. 2024;21:170.","journal-title":"J Neuroinflamm"},{"key":"8752_CR4","first-page":"54065","volume":"13","author":"MJ Hartsock","year":"2016","unstructured":"Hartsock MJ, Cho H, Wu L, Chen WJ, Gong J, Duh EJ. A mouse model of retinal ischemia-reperfusion injury through elevation of intraocular pressure. J Vis Exp. 2016;13:54065.","journal-title":"J Vis Exp"},{"key":"8752_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","volume":"21","author":"E Boada-Romero","year":"2020","unstructured":"Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21:398\u2013414.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8752_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran AC, Yurdagul A Jr., Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20:254\u201367.","journal-title":"Nat Rev Immunol"},{"key":"8752_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1172\/jci.insight.131355","volume":"4","author":"W Cai","year":"2019","unstructured":"Cai W, Dai X, Chen J, Zhao J, Xu M, Zhang L, et al. Stat6\/arg1 promotes microglia\/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight. 2019;4:20.","journal-title":"JCI Insight"},{"key":"8752_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/cns.13256","volume":"25","author":"W Zhang","year":"2019","unstructured":"Zhang W, Zhao J, Wang R, Jiang M, Ye Q, Smith AD, et al. Macrophages reprogram after ischemic stroke and promote efferocytosis and inflammation resolution in the mouse brain. CNS Neurosci Ther. 2019;25:1329\u201342.","journal-title":"CNS Neurosci Ther"},{"key":"8752_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe7915","volume":"6","author":"C Nakahashi-Oda","year":"2021","unstructured":"Nakahashi-Oda C, Fujiyama S, Nakazawa Y, Kanemaru K, Wang Y, Lyu W, et al. Cd300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke. Sci Immunol. 2021;6:eabe7915.","journal-title":"Sci Immunol"},{"key":"8752_CR10","first-page":"179","volume":"3","author":"S Kaur","year":"2020","unstructured":"Kaur S, Cicalese KV, Bannerjee R, Roberts DD. Preclinical and clinical development of therapeutic antibodies targeting functions of cd47 in the tumor microenvironment. Antib Ther. 2020;3:179\u201392.","journal-title":"Antib Ther"},{"key":"8752_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nm.3965","volume":"21","author":"RH Vonderheide","year":"2015","unstructured":"Vonderheide RH. Cd47 blockade as another immune checkpoint therapy for cancer. Nat Med. 2015;21:1122\u20133.","journal-title":"Nat Med"},{"key":"8752_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, et al. Cd47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86\u201390.","journal-title":"Nature"},{"key":"8752_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/ijms22084076","volume":"22","author":"L Sanchez-Moral","year":"2021","unstructured":"Sanchez-Moral L, R\u00e0fols N, Martori C, Paul T, T\u00e9llez \u00c9, Sarrias MR. Multifaceted roles of cd5l in infectious and sterile inflammation. Int J Mol Sci. 2021;22:8.","journal-title":"Int J Mol Sci"},{"key":"8752_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00281-018-0717-6","volume":"40","author":"S Arai","year":"2018","unstructured":"Arai S, Miyazaki T. A scavenging system against internal pathogens promoted by the circulating protein apoptosis inhibitor of macrophage (aim). Semin Immunopathol. 2018;40:567\u201375.","journal-title":"Semin Immunopathol"},{"key":"8752_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm.4012","volume":"22","author":"S Arai","year":"2016","unstructured":"Arai S, Kitada K, Yamazaki T, Takai R, Zhang X, Tsugawa Y, et al. Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med. 2016;22:183\u201393.","journal-title":"Nat Med"},{"key":"8752_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109693","volume":"36","author":"N Maehara","year":"2021","unstructured":"Maehara N, Taniguchi K, Okuno A, Ando H, Hirota A, Li Z, et al. Aim\/cd5l attenuates damps in the injured brain and thereby ameliorates ischemic stroke. Cell Rep. 2021;36:109693.","journal-title":"Cell Rep"},{"key":"8752_CR17","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcp.31097","volume":"238","author":"H Nemoto","year":"2023","unstructured":"Nemoto H, Honjo M, Arai S, Miyazaki T, Aihara M. Apoptosis inhibitor of macrophages\/cd5l enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension. J Cell Physiol. 2023;238:2451\u201367.","journal-title":"J Cell Physiol"},{"key":"8752_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.exer.2016.12.006","volume":"155","author":"A Iannaccone","year":"2017","unstructured":"Iannaccone A, Hollingsworth TJ, Koirala D, New DD, Lenchik NI, Beranova-Giorgianni S, et al. Retinal pigment epithelium and microglia express the cd5 antigen-like protein, a novel autoantigen in age-related macular degeneration. Exp Eye Res. 2017;155:64\u201374.","journal-title":"Exp Eye Res"},{"key":"8752_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1189\/jlb.3RU0215-074R","volume":"98","author":"L Sanjurjo","year":"2015","unstructured":"Sanjurjo L, Aran G, Roher N, Valledor AF, Sarrias MR. Aim\/cd5l: a key protein in the control of immune homeostasis and inflammatory disease. J Leukoc Biol. 2015;98:173\u201384.","journal-title":"J Leukoc Biol"},{"key":"8752_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2013.08.054","volume":"155","author":"P Li","year":"2013","unstructured":"Li P, Spann NJ, Kaikkonen MU, Lu M, Oh DY, Fox JN, et al. Ncor repression of lxrs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell. 2013;155:200\u2013214.","journal-title":"Cell"},{"key":"8752_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2010.04.013","volume":"11","author":"J Kurokawa","year":"2010","unstructured":"Kurokawa J, Arai S, Nakashima K, Nagano H, Nishijima A, Miyata K, et al. Macrophage-derived aim is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. Cell Metab. 2010;11:479\u201392.","journal-title":"Cell Metab"},{"key":"8752_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/950273","volume":"2013","author":"M Ferracini","year":"2013","unstructured":"Ferracini M, Rios FJ, Pecenin M, Jancar S. Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of cd36 and platelet-activating factor receptor. Mediat Inflamm. 2013;2013:950273.","journal-title":"Mediat Inflamm"},{"key":"8752_CR23","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1194\/jlr.M035352","volume":"54","author":"BW Parks","year":"2013","unstructured":"Parks BW, Black LL, Zimmerman KA, Metz AE, Steele C, Murphy-Ullrich JE, et al. Cd36, but not g2a, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury. J Lipid Res. 2013;54:1114\u201323.","journal-title":"J Lipid Res"},{"key":"8752_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/cells12010171","volume":"12","author":"R Yang","year":"2022","unstructured":"Yang R, Liu Q, Zhang M. The past and present lives of the intraocular transmembrane protein cd36. Cells. 2022;12:171.","journal-title":"Cells"},{"key":"8752_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.18632\/aging.100218","volume":"2","author":"E Picard","year":"2010","unstructured":"Picard E, Houssier M, Bujold K, Sapieha P, Lubell W, Dorfman A, et al. Cd36 plays an important role in the clearance of oxldl and associated age-dependent sub-retinal deposits. Aging (Albany NY). 2010;2:981\u2013989.","journal-title":"Aging (Albany NY)"},{"key":"8752_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41419-024-07002-z","volume":"15","author":"W Zhou","year":"2024","unstructured":"Zhou W, He J, Shen G, Liu Y, Zhao P, Li J. Trem2-dependent activation of microglial cell protects photoreceptor cell during retinal degeneration via ppar\u03b3 and cd36. Cell Death Dis. 2024;15:623.","journal-title":"Cell Death Dis"},{"key":"8752_CR27","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1128\/IAI.01195-10","volume":"79","author":"T Zou","year":"2011","unstructured":"Zou T, Garifulin O, Berland R, Boyartchuk VL. Listeria monocytogenes infection induces prosurvival metabolic signaling in macrophages. Infect Immun. 2011;79:1526\u201335.","journal-title":"Infect Immun"},{"key":"8752_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2004.09.032","volume":"119","author":"SB Joseph","year":"2004","unstructured":"Joseph SB, Bradley MN, Castrillo A, Bruhn KW, Mak PA, Pei L, et al. Lxr-dependent gene expression is important for macrophage survival and the innate immune response. Cell. 2004;119:299\u2013309.","journal-title":"Cell"},{"key":"8752_CR29","doi-asserted-by":"publisher","first-page":"17813","DOI":"10.1073\/pnas.0407749101","volume":"101","author":"AF Valledor","year":"2004","unstructured":"Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M, Glass CK. Activation of liver x receptors and retinoid x receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA. 2004;101:17813\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8752_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1053\/j.gastro.2007.11.037","volume":"134","author":"J Zhou","year":"2008","unstructured":"Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, et al. Hepatic fatty acid transporter cd36 is a common target of lxr, pxr, and ppargamma in promoting steatosis. Gastroenterology. 2008;134:556\u201367.","journal-title":"Gastroenterology"},{"key":"8752_CR31","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/scisignal.272re3","volume":"2","author":"RL Silverstein","year":"2009","unstructured":"Silverstein RL, Febbraio M. Cd36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2009;2:re3.","journal-title":"Sci Signal"},{"key":"8752_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1517\/14728222.2011.547853","volume":"15","author":"E Viennois","year":"2011","unstructured":"Viennois E, Pommier AJ, Mouzat K, Oumeddour A, El Hajjaji FZ, Dufour J, et al. Targeting liver x receptors in human health: Deadlock or promising trail? Expert Opin Ther Targets. 2011;15:219\u201332.","journal-title":"Expert Opin Ther Targets"},{"key":"8752_CR33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cdd.2016.24","volume":"23","author":"SR Larson","year":"2016","unstructured":"Larson SR, Atif SM, Gibbings SL, Thomas SM, Prabagar MG, Danhorn T, et al. Ly6c(+) monocyte efferocytosis and cross-presentation of cell-associated antigens. Cell Death Differ. 2016;23:997\u20131003.","journal-title":"Cell Death Differ"},{"key":"8752_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","volume":"30","author":"S Bhaskara","year":"2008","unstructured":"Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW, et al. Deletion of histone deacetylase 3 reveals critical roles in s phase progression and DNA damage control. Mol Cell. 2008;30:61\u201372.","journal-title":"Mol Cell"},{"key":"8752_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41419-023-06147-7","volume":"14","author":"E Shosha","year":"2023","unstructured":"Shosha E, Shahror RA, Morris CA, Xu Z, Lucas R, McGee-Lawrence ME, et al. The arginase 1\/ornithine decarboxylase pathway suppresses hdac3 to ameliorate the myeloid cell inflammatory response: Implications for retinal ischemic injury. Cell Death Dis. 2023;14:621.","journal-title":"Cell Death Dis"},{"key":"8752_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41419-018-1051-6","volume":"9","author":"AY Fouda","year":"2018","unstructured":"Fouda AY, Xu Z, Shosha E, Lemtalsi T, Chen J, Toque HA, et al. Arginase 1 promotes retinal neurovascular protection from ischemia through suppression of macrophage inflammatory responses. Cell Death Dis. 2018;9:1001.","journal-title":"Cell Death Dis"},{"key":"8752_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101273","volume":"53","author":"E Shosha","year":"2021","unstructured":"Shosha E, Fouda AY, Lemtalsi T, Haigh S, Fulton D, Ibrahim A, et al. Endothelial arginase 2 mediates retinal ischemia\/reperfusion injury by inducing mitochondrial dysfunction. Mol Metab. 2021;53:101273.","journal-title":"Mol Metab"},{"key":"8752_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yexcr.2019.04.008","volume":"380","author":"K Ou","year":"2019","unstructured":"Ou K, Mertsch S, Theodoropoulou S, Wu J, Liu J, Copland DA, et al. Restoring retinal neurovascular health via substance p. Exp Cell Res. 2019;380:115\u201323.","journal-title":"Exp Cell Res"},{"key":"8752_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.295","volume":"7","author":"E Shosha","year":"2016","unstructured":"Shosha E, Xu Z, Yokota H, Saul A, Rojas M, Caldwell RW, et al. Arginase 2 promotes neurovascular degeneration during ischemia\/reperfusion injury. Cell Death Dis. 2016;7:e2483.","journal-title":"Cell Death Dis"},{"key":"8752_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijms21155379","volume":"21","author":"DR Gutsaeva","year":"2020","unstructured":"Gutsaeva DR, Shalaby L, Powell FL, Thounaojam MC, Abouhish H, Wetzstein SA, et al. Inactivation of endothelial adam17 reduces retinal ischemia-reperfusion induced neuronal and vascular damage. Int J Mol Sci. 2020;21:15.","journal-title":"Int J Mol Sci"},{"key":"8752_CR41","first-page":"e50489","volume":"76","author":"JC Chou","year":"2013","unstructured":"Chou JC, Rollins SD, Fawzi AA. Trypsin digest protocol to analyze the retinal vasculature of a mouse model. J Vis Exp. 2013;76:e50489.","journal-title":"J Vis Exp"},{"key":"8752_CR42","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4745","volume":"13","author":"W Xiao","year":"2023","unstructured":"Xiao W, Shahror RA, Morris CA, Caldwell RB, Fouda AY. Multi-color flow cytometry protocol to characterize myeloid cells in mouse retina research. Bio Protoc. 2023;13:e4745.","journal-title":"Bio Protoc"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08752-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:01:46Z","timestamp":1780279306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08752-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8752"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08752-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirm that all experiments were performed in accordance with relevant guidelines and regulations and approved by the Animal Care and Use Committee of the University of Arkansas for Medical Sciences and, performed in accordance with the Association for Research in Vision and Ophthalmology (ARVO) guide for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"520"}}